Recent strategies and outcomes of transcatheter closure for patent ductus arteriosus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Management of PDA device closure complicated by severe hemolysis by transcatheter retrieval and deployment of new device.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
   Article
2. Hemolysis and its outcome following percutaneous closure of cardiac defects among children and adolescents: a prospective study.Italian journal of pediatrics · 2019
   Article
3. Do we have to close residual patent ductus arteriosus after surgery or transcatheter intervention?Korean circulation journal · 2011
   Article
4. Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less.Korean journal of pediatrics · 2010
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.